Related references
Note: Only part of the references are listed.Health state utilities for non small cell lung cancer
Beenish Nafees et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2008)
Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database
Taofeek K. Owonikoko et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
C. P. Belani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey
Jennifer L. Malin et al.
SUPPORTIVE CARE IN CANCER (2006)
Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials
RR Jennens et al.
INTERNAL MEDICINE JOURNAL (2006)
Chemotherapy for elderly patients with non-small cell lung cancer - A review of the evidence
C Gridelli et al.
CHEST (2005)
An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer
K Hotta et al.
LUNG CANCER (2004)
Population variations in the initial treatment of non-small-cell lung cancer
AL Potosky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: Evidence from Surveillance, Epidemiology and End Results-Medicare
SA Ramsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel
TA Hensing et al.
CANCER (2003)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Influence of age and comorbidities on the chemotherapeutic management of lung cancer
KM Deppermann
LUNG CANCER (2001)
Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis
CC Earle et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
The ELVIS trial: A phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer
C Gridelli
ONCOLOGIST (2001)
Who gets chemotherapy for metastatic lung cancer?
CC Earle et al.
CHEST (2000)
Share Paper
